Durability of antibody response to vaccination and surrogate neutralization of emerging variants based on SARS-CoV-2 exposure history

Durability of antibody response to vaccination and surrogate neutralization of emerging variants based on SARS-CoV-2 exposure history

Abstract Two-dose messenger RNA vaccines against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are highly effective in preventing symptomatic COVID-19 infection. However, the durability of protection is not known, nor is the effectiveness against emerging viral variants. Additiona...

Full description

Bibliographic Details
Main Authors:	Thomas W. McDade, Alexis R. Demonbreun, Amelia Sancilio, Brian Mustanski, Richard T. D’Aquila, Elizabeth M. McNally
Format:	Article
Language:	English
Published:	Nature Publishing Group 2021-08-01
Series:	Scientific Reports
Online Access:	https://doi.org/10.1038/s41598-021-96879-3

Similar Items

A surrogate virus neutralization test to quantify antibody-mediated inhibition of SARS-CoV-2 in finger stick dried blood spot samples
by: Amelia E. Sancilio, et al.
Published: (2021-07-01)

Comparison of IgG and neutralizing antibody responses after one or two doses of COVID-19 mRNA vaccine in previously infected and uninfected individuals.
by: Alexis R. Demonbreun, et al.
Published: (2021-08-01)

High seroprevalence for SARS-CoV-2 among household members of essential workers detected using a dried blood spot assay.
by: Thomas W McDade, et al.
Published: (2020-01-01)

Patterns and persistence of SARS-CoV-2 IgG antibodies in Chicago to monitor COVID-19 exposure
by: Alexis R. Demonbreun, et al.
Published: (2021-05-01)

Homogeneous surrogate virus neutralization assay to rapidly assess neutralization activity of anti-SARS-CoV-2 antibodies
by: Bansal, A., et al.
Published: (2022)

A simple protein-based surrogate neutralization assay for SARS-CoV-2
by: Kento T. Abe, et al.
Published: (2020-10-01)

Neutralizing Antibody Response of Vaccinees to SARS-CoV-2 Variants
by: Gabriele Anichini, et al.
Published: (2021-05-01)

Sex Disparities and Neutralizing-Antibody Durability to SARS-CoV-2 Infection in Convalescent Individuals
by: Alena J. Markmann, et al.
Published: (2021-08-01)

Broadly-Neutralizing Antibodies Against Emerging SARS-CoV-2 Variants
by: Lok Bahadur Shrestha, et al.
Published: (2021-09-01)

Increased resistance of SARS-CoV-2 Lambda variant to antibody neutralization
by: Cheng, L., et al.
Published: (2022)

Evaluation of a multi-species SARS-CoV-2 surrogate virus neutralization test
by: Carmen W.E. Embregts, et al.
Published: (2021-12-01)

Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants
by: Yiska Weisblum, et al.
Published: (2020-10-01)

Structural basis of nanobodies neutralizing SARS-CoV-2 variants
by: Chen, X., et al.
Published: (2022)

An investigation of adjustable microgravity workstation anthropometrics through analyses of neutral body posture and lower leg muscular fatigue characteristics
by: McDade, Theodore Pashley
Published: (2008)

Utility of Different Surrogate Enzyme-Linked Immunosorbent Assays (sELISAs) for Detection of SARS-CoV-2 Neutralizing Antibodies
by: Niko Kohmer, et al.
Published: (2021-05-01)

SARS-CoV-2 neutralizing antibodies: Longevity, breadth, and evasion by emerging viral variants.
by: Fiona Tea, et al.
Published: (2021-07-01)

SARS-CoV-2 protein subunit vaccination of mice and rhesus macaques elicits potent and durable neutralizing antibody responses
by: Marco Mandolesi, et al.
Published: (2021-04-01)

An intranasal vaccine durably protects against SARS-CoV-2 variants in mice
by: Ahmed O. Hassan, et al.
Published: (2021-07-01)

Resistance of SARS-CoV-2 variants to neutralization by antibodies induced in convalescent patients with COVID-19
by: Yu Kaku, et al.
Published: (2021-07-01)

Neutralizing activity of Sputnik V vaccine sera against SARS-CoV-2 variants
by: Satoshi Ikegame, et al.
Published: (2021-07-01)

SARS-CoV-2 binding and neutralizing antibody levels after Ad26.COV2.S vaccination predict durable protection in rhesus macaques
by: Ramon Roozendaal, et al.
Published: (2021-10-01)

Cross-neutralizing antibodies bind a SARS-CoV-2 cryptic site and resist circulating variants
by: Tingting Li, et al.
Published: (2021-09-01)

Neutralizing SARS-CoV-2
by: Eric Poeschla
Published: (2020-12-01)

A broadly neutralizing humanized ACE2-targeting antibody against SARS-CoV-2 variants
by: Yanyun Du, et al.
Published: (2021-08-01)

Epitope Classification and RBD Binding Properties of Neutralizing Antibodies Against SARS-CoV-2 Variants of Concern
by: Ashlesha Deshpande, et al.
Published: (2021-06-01)

Induction of Potent and Durable Neutralizing Antibodies Against SARS-CoV-2 Using a Receptor Binding Domain-Based Immunogen
by: Vikram Srivastava, et al.
Published: (2021-03-01)

Neutralizing antibody titres in SARS-CoV-2 infections
by: Eric H. Y. Lau, et al.
Published: (2021-01-01)

Duration of serum neutralizing antibodies for SARS-CoV-2: Lessons from SARS-CoV infection
by: Qingqing Lin, et al.
Published: (2020-10-01)

Durability and expansion of neutralizing antibody breadth following Ad26.COV2.S vaccination of mice
by: Barouch, D.H, et al.
Published: (2022)

Cross-Variant Neutralizing Serum Activity after SARS-CoV-2 Breakthrough Infections
by: Gruell, H., et al.
Published: (2022)

Neutralization of SARS-CoV-2 variants by convalescent and BNT162b2 vaccinated serum
by: Timothy A. Bates, et al.
Published: (2021-08-01)

The Study on Neutralization of Human Immunodeficiency Virus and SARS CoV-2 - Neutralization Resistance of SHIV and Neutralization Assay for SARS CoV-2 -
by: Pisil, Yalcin
Published: (2021)

Potent neutralization of SARS-CoV-2 variants of concern by an antibody with an uncommon genetic signature and structural mode of spike recognition
by: Kevin J. Kramer, et al.
Published: (2021-10-01)

Antibodies Targeting Two Epitopes in SARS-CoV-2 Neutralize Pseudoviruses with the Spike Proteins from Different Variants
by: Chee-Hing Yang, et al.
Published: (2021-07-01)

Computational design of a neutralizing antibody with picomolar binding affinity for all concerning SARS-CoV-2 variants
by: Adolf-Bryfogle, J., et al.
Published: (2022)

Sensitivity of SARS-CoV-2 Variants to Neutralization by Convalescent Sera and a VH3-30 Monoclonal Antibody
by: Shuai Yue, et al.
Published: (2021-09-01)

Resistance of SARS-CoV-2 Delta variant to neutralization by BNT162b2-elicited antibodies in Asians
by: Bei Wang, et al.
Published: (2021-10-01)

Modulation of septin 9 protein levels by alternative splicing
by: McDade, S. S.
Published: (2004)

Neutralizing antibodies targeting SARS-CoV-2 spike protein
by: Shi Xiaojie, et al.
Published: (2021-01-01)

Multivalency transforms SARS-CoV-2 antibodies into ultrapotent neutralizers
by: Edurne Rujas, et al.
Published: (2021-06-01)